Literature DB >> 389807

Synergistic antibacterial activity in vitro of trimethoprim and sulphonamides and the importance of pharmacokinetic properties for optimal therapy.

J K Seydel, E Wempe.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 389807     DOI： 10.1007/bf01639006

Source DB:  PubMed          Journal:  Infection        ISSN： 0300-8126            Impact factor:   3.553


× No keyword cloud information.
  11 in total

1.  The relation between the binding of sulfonamides to albumin and their antibacterial efficacy.

Authors:  A H ANTON
Journal:  J Pharmacol Exp Ther       Date:  1960-07       Impact factor: 4.030

2.  [Pharmacokinetic studies with the combination sulfamoxole/trimethoprim in animals and men (author's transl)].

Authors:  J Kuhne; F W Kohlmann; J K Seydel; E Wempe
Journal:  Arzneimittelforschung       Date:  1976

Review 3.  Trimethoprim-sulfamethoxazole: in vitro microbiological aspects.

Authors:  S R Bushby
Journal:  J Infect Dis       Date:  1973-11       Impact factor: 5.226

4.  Quantification of the antibacterial action of trimethoprim alone and in combination with sulfonamides by bacterial growth kinetics.

Authors:  J K Seydel; E Wempe; G H Miller; L Miller
Journal:  J Infect Dis       Date:  1973-11       Impact factor: 5.226

5.  The use of microbial kinetics in the quantification of antibiotic action.

Authors:  E R Garrett
Journal:  Arzneimittelforschung       Date:  1966-11

6.  Trimethoprim, a sulphonamide potentiator.

Authors:  S R Bushby; G H Hitchings
Journal:  Br J Pharmacol Chemother       Date:  1968-05

7.  Diffusion of sulfonamides from plasma into prostatic fluid.

Authors:  D G Winningham; T A Stamey
Journal:  J Urol       Date:  1970-10       Impact factor: 7.450

8.  Pharmacokinetics of sulfamethoxazole plus trimethoprim in man and their distribution in the rat.

Authors:  D E Schwartz; J Rieder
Journal:  Chemotherapy       Date:  1970       Impact factor: 2.544

9.  Kinetics and mechanisms of action of 'folate synthesis inhibitors', alone or in combination, on Escherichia coli. III. Pyrimethamine, trimethoprim and sulfamethoxazole.

Authors:  J K Seydel; E Wempe
Journal:  Chemotherapy       Date:  1975       Impact factor: 2.544

10.  [Studies on synergistic behaviour and pharmacokinetics of the combination sulfonamide/trimethoprim. IV. A comparative study on potentiating the trimethoprim effect by various sulfonamides and critical observations on its dosing (author's transl)].

Authors:  J K Seydel; E Wempe
Journal:  Arzneimittelforschung       Date:  1977
View more
  1 in total

1.  Trimethoprim/sulphonamide: concluding remarks.

Authors:  W Marget
Journal:  Infection       Date:  1979       Impact factor: 3.553
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.